Hua Medicine (Shanghai) Ltd.
HKEX:2552.HK
1.19 (HKD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 76.61 | 17.599 | 0 | 8.664 | 22.257 | 9.129 | 10.515 | 0.595 |
| Cost of Revenue
| 39.236 | 9.91 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 37.374 | 7.689 | 0 | 8.664 | 22.257 | 9.129 | 10.515 | 0.595 |
| Gross Profit Ratio
| 0.488 | 0.437 | 0 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 171.537 | 129.528 | 186.835 | 220.962 | 321.904 | 269.065 | 125.337 | 75.272 |
| General & Administrative Expenses
| 124.148 | 129.931 | 134.835 | 140.084 | 146.584 | 139.316 | 31.086 | 19.482 |
| Selling & Marketing Expenses
| 79.755 | 15.348 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 203.903 | 145.279 | 134.835 | 140.084 | 146.584 | 139.316 | 31.086 | 19.482 |
| Other Expenses
| 69.253 | -26.445 | -6.49 | -8.664 | -22.257 | -3,266.169 | -126.483 | -274.417 |
| Operating Expenses
| 326.466 | 248.362 | 315.18 | 352.382 | 446.231 | 399.252 | 145.908 | 94.159 |
| Operating Income
| -338.066 | -199.581 | -320.517 | -389.839 | -422.639 | -399.252 | -145.908 | -94.159 |
| Operating Income Ratio
| -4.413 | -11.34 | 0 | -44.995 | -18.989 | -43.734 | -13.876 | -158.25 |
| Total Other Income Expenses Net
| 126.832 | -3.926 | -5.217 | -3.295 | -2.631 | -3,204.746 | -134.78 | -268.249 |
| Income Before Tax
| -211.234 | -203.507 | -325.734 | -393.134 | -425.27 | -3,603.998 | -280.688 | -362.408 |
| Income Before Tax Ratio
| -2.757 | -11.564 | 0 | -45.376 | -19.107 | -394.786 | -26.694 | -609.089 |
| Income Tax Expense
| 134.739 | 0.259 | 5.217 | 3.295 | 2.631 | -3,201.212 | -141.581 | -265.738 |
| Net Income
| -211.234 | -203.766 | -330.951 | -396.429 | -427.901 | -3,602.726 | -272.714 | -361.328 |
| Net Income Ratio
| -2.757 | -11.578 | 0 | -45.756 | -19.225 | -394.646 | -25.936 | -607.274 |
| EPS
| -0.22 | -0.21 | -0.35 | -0.42 | -0.45 | -10.07 | -0.26 | -0.34 |
| EPS Diluted
| -0.22 | -0.21 | -0.35 | -0.42 | -0.45 | -10.07 | -0.26 | -0.34 |
| EBITDA
| -167.089 | -167.804 | -288.928 | -371.391 | -412.207 | -3,599.175 | -278.878 | -358.456 |
| EBITDA Ratio
| -2.181 | -9.535 | 0 | -42.866 | -18.52 | -394.257 | -26.522 | -602.447 |